Skip to main content
. 2019 Dec;60(12):621–625. doi: 10.11622/smedj.2019093

Fig. 1.

Fig. 1

Bar graphs show the comparison of (a) accelerated idioventricular rhythm; (b) frequent ventricular premature beat; and (c) ventricular tachycardia between the placebo-treated and rhBNP-treated groups. *p < 0.05; NS: not significant; rhBNP: recombinant human B-type natriuretic peptide